ArticleCancer cell international2019

AGI-134: a fully synthetic α-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models.

Stephen M Shaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.